文献速递核素与放射性配体治疗肿瘤 PET/CT

有机三氟硼酸盐增强成纤维细胞活化蛋白抑制剂用于靶向放射性核素治疗的肿瘤靶向性

Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-04-27

该研究在成纤维细胞活化蛋白抑制剂(FAPI)上引入有机三氟硼酸盐连接子,以提高肿瘤摄取与滞留,并便于18F标记用于PET引导α发射体治疗。在FAP表达荷瘤小鼠中,213Bi标记的该FAPI几乎完全抑制肿瘤生长且副作用可忽略;该策略也适用于引导212Bi、212Pb和149Tb等其他α发射体。

要点

  • 有机三氟硼酸盐连接子可提高FAPI在癌细胞中的内化,使肿瘤摄取明显增高而背景清晰。
  • 213Bi标记的该FAPI在FAP表达荷瘤小鼠中几乎完全抑制肿瘤生长,副作用可忽略。
  • 该策略普遍适用于引导212Bi、212Pb和149Tb等其他α发射体。

核心结论

  • 有机三氟硼酸盐连接子可能对优化FAP靶向放射性药物具有重要意义,短半衰期α发射体可能是快速清除的小分子放射性药物的选择。

研究设计与样本

  • 在FAPI上设计有机三氟硼酸盐连接子,并在FAP表达荷瘤小鼠中评估213Bi标记的该FAPI对肿瘤生长的抑制作用。

主要发现

  • 有机三氟硼酸盐连接子有助于提高癌细胞内的内化,导致肿瘤摄取明显更高而背景清晰。
  • 在FAP表达荷瘤小鼠中,213Bi标记的该FAPI几乎完全抑制肿瘤生长,同时副作用可忽略。
  • 额外数据显示该策略普遍适用于引导212Bi、212Pb和149Tb等其他α发射体。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Fibroblast activation protein (FAP) is a pan-cancer target and now the state-of-the-art to develop radiopharmaceuticals. FAP inhibitors have been of great success in developing imaging tracers. Yet, the overly rapid clearance cannot match with the long half-lives of regular therapeutic radionuclides. Though strategies that aim to elongate the circulation of FAPIs are being developed, here we describe an innovation that uses α-emitters of short half-lives (e.g., 213Bi) to pair the rapid pharmacokinetics of FAPIs. METHODS: An organotrifluoroborate linker is engineered to FAPIs to give two advantages: (1) selectively increases tumor uptake and retention; (2) facile 18F-radiolabeling for positron emission tomography to guide radiotherapy with α-emitters, which can hardly be traced in general. RESULTS: The organotrifluoroborate linker helps to improve the internalization in cancer cells, resulting in notably higher tumor uptake while the background is clean. In FAP-expressed tumor-bearing mice, this FAPI labeled with 213Bi, a short half-life α-emitter, exhibits almost complete suppression to tumor growth while the side effect is negligible. Additional data shows that this strategy is generally applicable to guide other α-emitters, such as 212Bi, 212Pb, and 149Tb. CONCLUSION: The organotrifluoroborate linker may be of importance to optimize FAP-targeted radiopharmaceuticals, and the short half-lived α-emitters may be of choice for the rapid-cleared small molecule-based radiopharmaceuticals.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Liu Y, Tang H, Song T, et al. Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy. Eur J Nucl Med Mol Imaging. 2023. PMID: 37103565. doi:10.1007/s00259-023-06230-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。